Ai Virtual Screening

Graph Neural Networks Drug Discovery

Development of GNN architectures for molecular property prediction and binding affinity estimation in virtual screening workflows.

RESEARCH GAP FRONTIERS

Physics-Informed Machine Learning Docking

Integration of physical constraints and force fields into neural network models for improved protein-ligand docking accuracy.

RESEARCH GAP FRONTIERS

Generative Models Molecular Design

Creation and optimization of generative adversarial networks and diffusion models for de novo ligand generation.

RESEARCH GAP FRONTIERS

Transfer Learning Cross-Domain Screening

Exploitation of pre-trained models across different target proteins and disease areas to improve screening efficiency.

RESEARCH GAP FRONTIERS

Quantum Machine Learning Molecular Properties

Application of quantum algorithms for accurate computation of quantum chemical descriptors in virtual screening.

RESEARCH GAP FRONTIERS

Attention Mechanisms Protein-Ligand Interactions

Development of transformer-based models with attention mechanisms to identify critical interaction points in docking.

RESEARCH GAP FRONTIERS

Uncertainty Quantification Scoring Functions

Implementation of Bayesian deep learning methods to provide confidence estimates for binding predictions.

RESEARCH GAP FRONTIERS

Multi-Task Learning Target Selectivity

Design of multi-task neural networks for simultaneous prediction of binding and selectivity across multiple targets.

RESEARCH GAP FRONTIERS

Reinforcement Learning Compound Optimization

Use of RL algorithms to iteratively optimize molecular structures according to multi-objective screening criteria.

Federated Learning Distributed Drug Screening

Development of privacy-preserving federated learning frameworks for collaborative virtual screening across institutions.

Explainable AI Binding Prediction Interpretability

Creation of interpretable machine learning models that reveal chemical features driving ligand binding predictions.

3D Convolutional Networks Molecular Geometry

Application of 3D CNN architectures to process volumetric molecular representations for enhanced screening.

Ensemble Methods Virtual Screening Robustness

Integration of multiple diverse screening models through ensemble techniques to reduce false positives.

Active Learning Experimental Validation Design

Use of active learning strategies to intelligently select compounds for experimental testing based on prediction uncertainty.

Knowledge Graph Embedding Target Interaction

Application of knowledge graph embeddings to predict drug-target interactions using biological relationship networks.

Molecular Dynamics Deep Learning Integration

Combining molecular dynamics simulations with deep learning to predict binding kinetics and thermodynamics.

Natural Language Processing Biomedical Literature Mining

Extraction of drug-target relationships and bioactivity data from scientific literature using advanced NLP techniques.

Contrastive Learning Molecular Representation

Development of self-supervised contrastive learning methods for learning robust molecular embeddings.

Meta-Learning Few-Shot Screening

Application of meta-learning approaches to perform accurate screening with limited labeled data for novel targets.

Variational Autoencoders Chemical Space Exploration

Use of VAEs to map and navigate chemical space for targeted exploration of promising compounds.

Temporal Graph Networks Drug Efficacy Prediction

Application of temporal graph networks to model dynamic protein-ligand interactions over time.

Adversarial Training Robustness Screening

Development of adversarially robust screening models resistant to molecular perturbations and distribution shifts.

Structure-Activity Relationship Deep Learning Models

Construction of neural network SAR models capturing complex non-linear structure-activity relationships.

Pharmacophore Detection Neural Networks

Automatic identification of pharmacophoric patterns using deep learning for ligand-based virtual screening.

Molecular Fragment Assembly Generative Models

Development of fragment-based generative models for constructing novel drug candidates with desired properties.

Protein Pocket Prediction Deep Learning

Application of deep learning to predict druggable binding pockets from protein structure data.

Cross-Modal Learning Structure Activity Relationship

Integration of multiple molecular representations through cross-modal learning for comprehensive screening.

Crystallographic Data Neural Network Training

Leveraging high-resolution crystal structures to train more accurate neural network scoring functions.

Off-Target Toxicity Prediction AI

Development of machine learning models predicting off-target binding and potential toxicity liabilities.

Solubility Permeability Prediction Integration

Combined AI modeling of drug-like properties alongside binding prediction for comprehensive ADMET assessment.

Rare Event Classification Virtual Screening

Application of specialized machine learning techniques for identifying rare but potent binder classes.

Synthetic Accessibility AI Screening Integration

Integration of synthetic feasibility prediction into virtual screening workflows for practical compound selection.

Protein Flexibility Docking Prediction

Neural network modeling of protein conformational changes to improve binding prediction accuracy.

Machine Learning Allosteric Site Discovery

AI-driven identification and characterization of allosteric binding sites for novel drug development.

Solvation Energy Neural Network Prediction

Deep learning models for accurate implicit and explicit solvation free energy calculations in screening.

Mutation Effect Prediction Selectivity

Machine learning prediction of binding changes upon protein mutations for selectivity optimization.

Sparse Data Deep Learning Screening

Development of efficient neural architectures for virtual screening with limited training data availability.

Protein-Protein Interaction Modulation Prediction

AI models predicting compounds that modulate protein-protein interactions relevant to disease.

Bioavailability Prediction Machine Learning

Neural network models integrating multiple pharmacokinetic factors for comprehensive bioavailability prediction.

Multi-Target Drug Discovery AI Platform

Integrated AI systems for simultaneous screening against multiple disease-relevant targets.

Cheminformatics Feature Engineering Automation

Automated discovery and optimization of chemical descriptors for improved screening model performance.

Binding Mode Prediction Classification Networks

Deep learning classification of distinct binding modes to compounds within protein pockets.

Chemical Space Diversity Assessment AI

Machine learning methods for evaluating and optimizing chemical diversity in screening libraries.

Structure Similarity Neural Network Metrics

Development of learned similarity metrics capturing meaningful molecular relationships for screening.

Metabolite Prediction Liability Assessment

AI models predicting compound metabolism pathways and identifying potential metabolic liabilities.

Blind Docking Prediction Deep Learning

Neural networks for predicting binding sites and affinities without prior structural knowledge.

PAINS Filter Machine Learning Optimization

AI-driven optimization of compound filtering criteria beyond traditional PAINS rules.

Ligand Lipophilicity Prediction Optimization

Machine learning models for predicting and optimizing lipophilicity in virtual screening workflows.

Quantum Mechanical Descriptor Integration AI

Incorporation of quantum mechanical properties into AI screening models for enhanced accuracy.

Patient-Specific Drug Response Prediction

Personalized AI models predicting individual patient drug responses based on genetic and molecular factors.

Equivariant Neural Networks Molecular Symmetry

Develops SE(3)-equivariant architectures that respect rotational and translational symmetries in molecular structure prediction for improved screening accuracy.

Diffusion Models Generative Drug Design

Applies score-based diffusion models to generate novel drug candidates by learning continuous transformations in chemical space.

Graph Isomorphism Network Binding Affinity

Utilizes graph isomorphism principles to improve molecular graph representations for accurate binding affinity predictions in virtual screening.

Topological Data Analysis Molecular Landscapes

Applies persistent homology and TDA methods to identify topological features in chemical space for drug discovery applications.

Causal Inference Drug Target Discovery

Integrates causal reasoning frameworks to identify true drug-target relationships and distinguish correlation from causation in screening data.

Bayesian Optimization High-Throughput Screening

Develops Gaussian process-based acquisition functions for efficient exploration of chemical space in computational screening campaigns.

Protein Language Models Interaction Prediction

Leverages pre-trained protein sequence models to predict protein-ligand interactions without explicit structural information.

Mixture of Experts Screening Ensemble

Develops gated mixture-of-experts architectures that dynamically select specialized screening models based on molecular properties.

Homology Modeling Uncertainty Deep Learning

Quantifies uncertainty in homology-modeled protein structures and propagates it through screening pipelines for robust predictions.

Scaffold Hopping Neural Networks

Designs generative models that identify and generate scaffold transformations maintaining bioactivity during virtual screening exploration.

Ion Channel Selectivity Prediction AI

Develops specialized neural networks for predicting ligand selectivity across ion channel superfamilies using structural and sequence data.

Kinase Binding Mode Classification

Creates deep learning classifiers to predict type I II and III binding modes in kinase virtual screening applications.

Chimeric Model Ensemble Consensus Scoring

Combines physically-informed and data-driven scoring functions through learned ensemble weighting for improved virtual screening performance.

Membrane Partitioning Prediction Neural Networks

Develops models to predict membrane insertion and partitioning behavior of ligands for ADME-aware virtual screening.

Nucleotide Binding Affinity Deep Learning

Applies specialized neural architectures to predict binding affinities for nucleotide-binding proteins in virtual screening workflows.

Conformational Ensemble Sampling Deep Learning

Trains models to efficiently sample and score ligands against conformational ensembles of target proteins for dynamic screening.

Privileged Structure Recognition Machine Learning

Develops systems to identify and exploit privileged pharmacophoric scaffolds across multiple targets in virtual screening.

Water Molecule Mediation Binding Prediction

Predicts water-mediated interactions and ordered water molecules in protein-ligand complexes for accurate binding assessment.

Covalent Reactivity Prediction Models

Develops machine learning models to predict covalent modification potential and reactivity patterns in virtual screening.

Allosteric Modulator Prediction Neural Networks

Creates specialized networks for identifying allosteric modulators distinct from orthosteric binders in screening applications.

Rare Genetic Variant Target Adaptation

Develops transfer learning approaches to adapt screening models for rare genetic variants of drug targets.

pH-Dependent Binding State Prediction

Models ionization state changes and pH-dependent binding modes for physiologically relevant virtual screening.

Multi-Objective Molecular Optimization Pareto

Applies Pareto optimization and multi-objective machine learning to balance multiple drug properties in screening.

Protein Stability Affinity Trade-off Learning

Models the interplay between binding affinity and protein stability to predict functional binding events.

Epigenetic Modulation Screening Deep Learning

Develops models to predict epigenetic modulator activity including histone and chromatin remodeler interactions.

Structural Homology Transfer Learning Selectivity

Applies homology-based transfer learning to predict ligand selectivity across structurally similar protein targets.

Carbohydrate Binding Recognition Networks

Develops specialized architectures for modeling carbohydrate-protein interactions in screening applications.

Photodynamic Therapy Agent Prediction

Creates models to predict photodynamic properties and cellular uptake of therapeutic agents in virtual screening.

Immunogenicity Prediction Sequence Models

Combines sequence and structure models to predict immunogenic epitopes and immunogenicity of drug candidates.

Lipophilic Efficiency Optimization Networks

Develops multi-task networks optimizing lipophilic efficiency and other efficiency metrics simultaneously in screening.

Prodrug Activation Prediction Learning

Models metabolic activation pathways and prodrug conversion efficiency for design of activatable therapeutics.

Protein Intrinsic Disorder Binding Prediction

Develops models specific to intrinsically disordered protein regions and their unique binding characteristics.

Transporter Substrate Recognition Classification

Creates classifiers to predict substrate specificity and transport potential for major drug transporters.

Zinc-Coordinating Ligand Prediction Networks

Develops specialized networks for metalloprotein-ligand docking and zinc coordination geometry prediction.

Cryptic Pocket Detection Deep Learning

Identifies cryptic and transient binding pockets using molecular dynamics ensembles and deep learning.

Cyclic Peptide Scaffold Docking

Develops specialized docking and scoring approaches for cyclic peptide library screening applications.

Disease Progression Biomarker Prediction

Integrates screening results with disease progression models to predict long-term therapeutic outcomes.

Enzyme Inhibition Kinetics Prediction

Develops models to predict enzyme inhibition kinetics including Km and Vmax modulation from structures.

Fragment-Based Lead Discovery Networks

Applies machine learning to predict fragment binding and optimize fragment-to-lead progression in screening.

G-Protein Coupled Receptor Selectivity

Creates specialized models for GPCR-ligand selectivity prediction incorporating transmembrane topology.

Hydrogen Bond Geometry Scoring Networks

Develops learned scoring functions that accurately model hydrogen bonding geometry and directionality.

In Silico Toxicology Mechanism Learning

Predicts molecular mechanisms of toxicity and identifies structural toxicophores using mechanistic learning.

Joint Embedding Protein Ligand Spaces

Learns joint embedding spaces between protein structures and ligands for improved screening representations.

Kinase Portal Region Binding Prediction

Develops models for the allosteric portal region in kinases enabling back-pocket binder discovery.

Ligand Entropy Estimation Deep Learning

Estimates ligand conformational entropy directly from structures for improved free energy predictions.

Mycobacterial Cell Wall Permeation

Models M. tuberculosis cell wall penetration and efflux resistance for TB drug screening optimization.

Necroptosis Pathway Target Prediction

Develops models to identify and predict compounds targeting necroptosis pathway components.

Organ-on-Chip Prediction Learning

Transfers in vitro organ-chip model predictions to whole-organism pharmacokinetics using machine learning.

Patch-Based Scoring Function Learning

Develops local patch-based neural network scoring functions for improved binding site recognition.

Quantum Yield Prediction Photochemistry

Predicts photochemical properties and quantum yields for phototherapeutic compound screening.

Topological Data Analysis Drug Screening

Application of persistent homology and topological methods to identify hidden structural patterns in chemical space for virtual screening optimization.

Bayesian Deep Learning Binding Confidence

Integration of Bayesian neural networks to quantify epistemic and aleatoric uncertainty in binding affinity predictions for robust screening.

Capsule Networks Protein Conformational States

Implementation of capsule network architectures to model dynamic protein conformational ensembles in virtual drug screening applications.

Self-Supervised Learning Unlabeled Screening Data

Development of contrastive and predictive self-supervised methods to leverage vast unlabeled chemical and biological data in virtual screening.

Graph Isomorphism Networks Molecular Matching

Application of GIN architectures for accurate molecular graph comparison and similarity assessment in large-scale virtual screening databases.

Neural ODE Drug Binding Kinetics

Modeling continuous-time binding dynamics using neural ordinary differential equations for improved kinetic parameter prediction in screening.

Causal Inference Target Validation Screening

Application of causal inference methods to identify genuine target interactions and distinguish causal from correlative binding signals.

Hypergraph Neural Networks Multi-Body Interactions

Development of hypergraph-based models to capture complex multi-molecule and multi-target interaction networks in virtual screening.

Attention-Based Protein Sequence Alignment

Creation of attention mechanisms for protein sequence comparison to enhance homology-based target selection in drug screening.

Normalizing Flows Molecular Generation Screening

Implementation of flow-based generative models for efficient sampling from high-probability regions of drug-like chemical space.

Set Transformer Binding Site Recognition

Application of permutation-invariant transformer architectures to identify and characterize multiple binding pockets in protein structures.

Neural Architecture Search Screening Models

Automated discovery of optimal neural network architectures for specific virtual screening tasks through NAS optimization.

Protein Language Models Binding Prediction

Leveraging pre-trained protein language models to encode sequence information for improved target-ligand interaction prediction.

Mixture of Experts Virtual Screening

Development of sparse mixture-of-experts architectures to specialize prediction across diverse ligand and target chemical spaces.

Diffusion Models Molecular Optimization

Application of denoising diffusion probabilistic models for iterative refinement and generation of optimized drug candidates in screening.

Molecular Transformers Property Prediction

Implementation of transformer architectures with molecular tokenization for predicting multi-property profiles in compound screening.

Harmonic Analysis Chemical Space

Application of spectral methods and harmonic analysis to understand manifold structure of drug-like molecules in screening databases.

Neuro-Symbolic Binding Mechanism Reasoning

Integration of neural networks with symbolic reasoning to explain and predict ligand-protein binding mechanisms in virtual screening.

Schrödinger-Equation Informed Neural Networks

Incorporation of quantum mechanical principles directly into neural network architectures for physics-consistent molecular property prediction.

Optimal Transport Molecular Similarity

Application of Wasserstein distances and optimal transport theory for computing chemically meaningful molecular similarity metrics.

Federated Learning Multi-Institution Screening

Development of privacy-preserving federated learning frameworks enabling collaborative virtual screening across multiple pharmaceutical organizations.

Metalearning Drug Reposition Fast Adaptation

Application of meta-learning techniques for rapid adaptation to new target classes in drug repositioning screening tasks.

Geometric Deep Learning Binding Pose

Development of geometric deep learning methods that respect molecular and protein geometric constraints for binding pose prediction.

Continual Learning Incremental Screening

Implementation of continual learning strategies to update virtual screening models with new experimental data without catastrophic forgetting.

Point Cloud Networks Protein Structure

Application of 3D point cloud neural networks for processing raw atomic coordinates in protein-ligand interaction prediction.

Symbolic Regression Chemical Descriptor Generation

Use of symbolic regression techniques to automatically discover interpretable chemical descriptors optimal for screening tasks.

Recurrent Neural Networks Time-Dependent Binding

Development of RNN models to predict temporal evolution of ligand-protein binding interactions during molecular dynamics simulations.

Attention Pooling Multi-Conformation Screening

Implementation of attention-based pooling mechanisms to aggregate predictions across multiple protein conformations in ensemble screening.

Curriculum Learning Drug Discovery Difficulty

Application of curriculum learning to progressively train screening models on increasingly complex molecular examples.

Homomorphism Neural Networks Molecular Motifs

Development of neural networks based on graph homomorphisms to identify and leverage recurring molecular motifs in screening.

Stochastic Weight Averaging Ensemble Stability

Application of SWA techniques to improve ensemble robustness and generalization in virtual screening predictions.

Implicit Neural Representations Binding Surfaces

Development of implicit neural function representations for continuous modeling of protein binding surface properties.

Gradient-Based Molecule Editing REINVENT

Implementation of gradient-based optimization for molecular structure modification toward desired properties in screening.

Cross-Entropy Methods Compound Sampling

Application of cross-entropy methods for adaptive sampling of promising regions in large chemical libraries during screening.

Spectral Methods Protein Dynamics Screening

Use of spectral decomposition of dynamical systems to characterize protein flexibility effects on virtual screening accuracy.

Recombination Networks Chemical Fragment Linking

Development of neural networks for predicting compatibility and optimal linking of chemical fragments during compound design.

Inverse Design Neural Networks Target Ligands

Creation of inverse neural network models to design ligands with specified binding properties without explicit enumeration.

Weak Supervision Binding Label Aggregation

Application of weak supervision and label aggregation techniques to leverage imperfect binding affinity labels in screening.

Coarse-Grained Molecular Models Deep Learning

Integration of coarse-grained molecular representations with deep learning for large-scale protein-ligand screening.

Conformal Predictions Screening Confidence Bounds

Application of conformal prediction methods to generate distribution-free confidence intervals for binding predictions.

Invariant Networks Molecular Property Prediction

Development of permutation-invariant neural networks for predicting molecular properties independent of atom ordering.

Optimal Control Molecular Trajectory Screening

Application of optimal control theory to predict optimal binding pathways and transition states in screening simulations.

Belief Propagation Graph Inference Screening

Implementation of belief propagation algorithms on molecular and biological networks for improved screening predictions.

Kernel Methods High-Dimensional Screening Space

Application of advanced kernel methods for handling high-dimensional feature spaces in virtual screening tasks.

Latent Variable Models Hidden Binding States

Development of variational models to infer hidden binding states and intermediate complexes in screening simulations.

Regularization Techniques Overfitting Prevention Screening

Investigation of advanced regularization methods including spectral normalization for preventing overfitting in screening models.

Attention Visualization Binding Mechanism Explanation

Development of visualization techniques for attention weights to interpret neural network predictions of molecular binding.

Hybrid Classical-Quantum Virtual Screening

Integration of classical deep learning with quantum computing approaches for enhanced molecular property estimation in screening.

Equivariant Neural Networks Molecular Conformation

Develops SE(3)-equivariant architectures that respect rotational and translational symmetries for improved 3D molecular structure prediction and screening.

Homology Modeling Deep Learning Receptor Structure

Integrates machine learning with comparative modeling to predict target protein structures lacking experimental data for virtual screening applications.

Hydrogen Bond Network Prediction Machine Learning

Applies neural networks to identify and predict hydrogen bonding patterns critical for compound binding affinity and selectivity.

Halogen Bonding Interactions Deep Learning Detection

Develops AI models to recognize and score halogen bonding interactions often missed by conventional docking algorithms.

Pi-Stacking Aromatic Interaction Neural Network Scoring

Creates machine learning scoring functions specifically trained to capture pi-pi and cation-pi stacking contributions to binding energy.

Salt Bridge Formation Prediction Machine Learning

Builds AI models to predict electrostatic interactions and salt bridge formation between ligands and protein residues.

Entropy-Enthalpy Decomposition Deep Learning

Applies neural networks to decompose binding free energy into entropic and enthalpic contributions for mechanistic understanding.

Allosteric Modulation Prediction Neural Networks

Develops machine learning models to identify allosteric binding sites and predict compounds modulating protein conformational states.

Protein Dynamics Conformational Sampling Deep Learning

Integrates molecular dynamics trajectories with neural networks to account for protein flexibility in virtual screening.

Ligand Desolvation Penalty Prediction Machine Learning

Develops AI models to predict desolvation costs accompanying ligand binding based on hydration shell disruption.

Lipophilicity Optimization Neural Network Guidance

Creates machine learning models to guide compound optimization towards optimal lipophilicity-efficacy balance.

Metabolic Stability Prediction Enzyme Kinetics

Combines deep learning with enzyme kinetics modeling to predict metabolic stability and clearance pathways.

CYP450 Interaction Prediction Machine Learning

Develops neural network models to predict cytochrome P450-mediated metabolism and drug-drug interaction potential.

Blood-Brain Barrier Penetration Deep Learning

Applies machine learning to predict BBB permeability and design compounds with optimal CNS exposure properties.

Plasma Protein Binding Prediction AI Models

Trains neural networks on experimental binding data to predict human serum albumin and lipoprotein interactions.

Cardiac Toxicity hERG Channel Prediction

Develops deep learning models to predict hERG channel binding and QT prolongation liability early in screening.

Genotoxicity ADMET Risk Assessment Neural Networks

Creates machine learning classifiers to predict genotoxicity and other critical ADMET liabilities from structure.

Immunogenicity Prediction Epitope Mapping Deep Learning

Applies neural networks to predict immunogenic epitopes and antibody responses to therapeutic compounds.

Microsomal Stability Intrinsic Clearance Prediction

Develops machine learning models to predict microsomal stability and intrinsic clearance from compound structure.

Machine Learning Drug Repurposing Target Discovery

Uses neural networks to identify new therapeutic targets and applications for existing approved drugs.

Polypharmacology Network Analysis Machine Learning

Applies graph neural networks to map compound off-target interactions and predict polypharmacological effects.

Selectivity Prediction Multi-Target Deep Learning

Develops neural network architectures to simultaneously predict binding affinities across target families for selectivity assessment.

Isoform-Selective Binding Prediction Machine Learning

Creates AI models to predict selective binding to protein isoforms with high sequence similarity.

Conformational Selectivity Docking Deep Learning

Develops neural network methods to predict ligand selectivity based on conformational adaptation requirements.

Binding Kinetics Association Dissociation Prediction

Applies machine learning to predict ligand-target association and dissociation rates from equilibrium data.

Virtual Screening Cancer Cell Line Sensitivity

Integrates genomic data with molecular docking to predict compound sensitivity across diverse cancer cell line models.

Oncogenic Mutation Responsive Compound Prediction

Develops deep learning models to identify compounds targeting specific cancer-causing mutations.

Protein-Ligand Solvation Thermodynamics Neural Networks

Creates machine learning models incorporating explicit solvent effects for improved binding affinity prediction.

Machine Learning QSAR Toxicophore Identification

Applies interpretable neural networks to identify structural motifs responsible for toxicity in compound libraries.

Epigenetic Target Virtual Screening Deep Learning

Develops AI screening pipelines for epigenetic modifiers targeting histone modifications and chromatin remodeling.

Protein-Protein Interaction Inhibitor Prediction AI

Creates neural network models to identify and optimize inhibitors of challenging protein-protein interaction interfaces.

RNA Target Binding Deep Learning Prediction

Develops machine learning methods to predict small molecule binding to RNA secondary structures and motifs.

Membrane Protein Docking Deep Learning Models

Creates specialized neural network architectures for docking against transmembrane and membrane-bound proteins.

Ion Channel Blocker Prediction Machine Learning

Applies deep learning to predict selective ion channel blocking and modulation in electrophysiology.

G-Protein Coupled Receptor Ligand Prediction

Develops neural network screening methods for GPCR agonists, antagonists, and biased ligands.

Kinase Selectivity Network Deep Learning Modeling

Creates machine learning models to navigate kinase selectivity and predict off-target kinase interactions.

Nuclear Receptor Agonist Antagonist Prediction

Applies deep learning to distinguish agonists from antagonists and predict transactivation profiles.

Protease Substrate Specificity Deep Learning

Develops neural network models to predict protease cleavage selectivity and inhibitor design.

Ubiquitin Proteasome System Targeting Deep Learning

Creates machine learning methods to predict E3 ligase substrate specificity and design PROTACs.

Autophagy Modulator Prediction Machine Learning

Applies neural networks to identify compounds modulating autophagy pathways for neurodegeneration and cancer.

Immune Checkpoint Inhibitor Prediction Deep Learning

Develops AI screening for immune checkpoint protein inhibitors with optimized immunogenicity profiles.

Antimicrobial Peptide Design Machine Learning

Creates neural network models to design and optimize antimicrobial peptides with reduced cytotoxicity.

Antibiotic Resistance Prediction Structural Genomics

Applies machine learning to predict antibiotic resistance mechanisms and identify new antibiotic scaffolds.

Viral Protein Inhibitor Design Deep Learning

Develops neural network screening for antivirals targeting conserved viral protein structures.

Natural Product Virtual Screening Deep Learning

Creates AI methods for mining natural product databases and predicting bioactivity of plant-derived compounds.

Scaffold Hopping Machine Learning Analog Generation

Applies neural networks to identify novel chemical scaffolds with retained target activity and improved ADMET.

Bioisostere Replacement Deep Learning Prediction

Develops machine learning models to predict successful bioisosteric replacements maintaining binding efficacy.

Privileged Structure Machine Learning Identification

Uses neural networks to identify and exploit privileged molecular scaffolds across multiple therapeutic areas.

Fragment-Based Drug Discovery Deep Learning Assembly

Applies machine learning to predict fragment binding poses and optimal linking strategies in FBDD campaigns.

Combinatorial Library Design AI Optimization

Creates neural network algorithms to design focused combinatorial libraries maximizing hit probability.

Equivariant Neural Networks Conformational Sampling

Leverages SE(3)-equivariant architectures to predict ligand conformational ensembles and protein-ligand binding poses while preserving geometric invariances for improved virtual screening accuracy.

Diffusion Models Generative Pose Prediction

Applies score-based diffusion models to generate and rank probable ligand binding modes by iteratively refining poses through learned molecular geometry distributions for enhanced docking predictions.